Jäkälä P, Sirviö J, Jolkkonen J, Riekkinen P, Acsady L, Riekkinen P
Department of Neurology, University of Kuopio, Finland.
Behav Brain Res. 1992 Oct 31;51(1):29-40. doi: 10.1016/s0166-4328(05)80309-2.
The effects of serotonergic dysfunction induced by treatment with p-chlorophenylalanine (PCPA), an inhibitor of serotonin synthesis, and cholinergic dysfunction induced by scopolamine on the performance of adult rats in the 5-choice serial reaction time task measuring selective attention were studied. Food-deprived rats were trained to detect and respond to brief flashes of light presented randomly in one of five locations, until they reached a stable level of performance (about 4 months). Scopolamine 0.2 mg/kg produced a marked variation in the performance but did not, however, induce any consistent impairment in the discriminative accuracy. Other doses of scopolamine (0.05 and 0.1 mg/kg) or N-methyl-scopolamine 0.2 mg/kg, a peripheral muscarinic receptor antagonist, did not affect discriminative accuracy. Furthermore, scopolamine as well as N-methyl-scopolamine produced a number of other performance deficits, such as significantly decreased overall probability of responding and significantly increased response latencies. PCPA treatment induced an almost total depletion (> 99%) of frontal cortical serotonin and its major metabolite 5-HIAA and reduced the frontal cortical concentrations of noradrenaline (-30%) and dopamine (-42%). During baseline testing conditions, there was a trend for the discriminative accuracy to be decreased by PCPA, although this effect failed to reach significance (P = 0.07). Presenting the stimuli at unpredictable intervals or reducing the intensity of the visual stimulus impaired discriminative accuracy in both PCPA-treated and control rats. The decrease in discriminative accuracy induced by PCPA reached statistical significance when the stimuli were presented faster than normally or the intensity of the visual stimulus was reduced. PCPA treatment did not make the rats more susceptible to the effects of scopolamine on discriminative accuracy. However, PCPA treatment also induced a number of other performance deficits, resulting in a decreased overall tendency to respond. In summary, there is a statistically non-significant trend for the discriminative accuracy to be decreased by PCPA treatment under normal testing conditions, and as the discrimination task is made more difficult (stimulus intensity reduction, presentation of the stimuli at faster than normal rates), the deficit in discriminative accuracy produced by PCPA treatment is revealed. The results suggest a role for brain serotonin in the general organization of behavior.
研究了5-羟色胺合成抑制剂对氯苯丙氨酸(PCPA)诱导的5-羟色胺能功能障碍以及东莨菪碱诱导的胆碱能功能障碍对成年大鼠在测量选择性注意力的5选连续反应时任务中的表现的影响。将食物剥夺的大鼠训练以检测并对在五个位置之一随机呈现的短暂闪光做出反应,直到它们达到稳定的表现水平(约4个月)。0.2mg/kg的东莨菪碱使表现产生显著变化,但未对辨别准确性造成任何持续损害。其他剂量的东莨菪碱(0.05和0.1mg/kg)或外周毒蕈碱受体拮抗剂N-甲基东莨菪碱0.2mg/kg不影响辨别准确性。此外,东莨菪碱以及N-甲基东莨菪碱还产生了许多其他表现缺陷,如反应的总体概率显著降低以及反应潜伏期显著增加。PCPA处理导致额叶皮质5-羟色胺及其主要代谢产物5-羟吲哚乙酸几乎完全耗竭(>99%),并使额叶皮质去甲肾上腺素浓度降低(-30%)和多巴胺浓度降低(-42%)。在基线测试条件下,PCPA有使辨别准确性降低的趋势,尽管该效应未达到显著水平(P=0.07)。以不可预测的间隔呈现刺激或降低视觉刺激的强度会损害PCPA处理组和对照组大鼠的辨别准确性。当刺激呈现速度比正常快或视觉刺激强度降低时,PCPA诱导的辨别准确性降低达到统计学显著水平。PCPA处理并未使大鼠对东莨菪碱对辨别准确性的影响更敏感。然而,PCPA处理也诱导了许多其他表现缺陷,导致反应的总体倾向降低。总之,在正常测试条件下,PCPA处理使辨别准确性降低的趋势在统计学上不显著,并且随着辨别任务变得更困难(刺激强度降低、以比正常更快的速度呈现刺激),PCPA处理产生的辨别准确性缺陷会显现出来。结果表明脑5-羟色胺在行为的总体组织中起作用。